Pfizer Inc. chief executive Albert Bourla praised the Trump administration’s latest pick to lead the Centers for Disease ...
Matthew Herper covers medical innovation — both its promise and its perils. Pfizer CEO Albert Bourla on Wednesday defended the development of Covid vaccinations, including Pfizer’s own, suggesting ...
Q1 2026 Management View Pfizer reported a Q1 it framed as operationally strong, with Chairman and CEO Albert Bourla saying, "We've had a strong start to the year. Our business continues to perform ...
Pfizer (NYSE:PFE) used its 2026 annual meeting of shareholders to highlight recent operational performance, outline strategic ...
Pfizer's 6.5% Dividend Yield Looked Too Good to Be True -- but Management Just Silenced the Skeptics
While Pfizer's dividend yield may have looked too good to be true for some investors, that shouldn't be the case now. The ...
Pfizer (PFE) CEO and chairman Albert Bourla told Yahoo Finance Executive Editor Brian Sozzi during Yahoo Finance's annual Investconference that the $10 billion acquisition of GLP-1 maker Metsera (MTSR ...
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, recently announced that he will step down from his position in December. Some social media users claim another ...
As the CEO of Pfizer, Albert Bourla led the team behind one of the most consequential medical breakthroughs of the modern era: the COVID-19 vaccine that saved millions of lives. Yet the leadership ...
Pfizer's Ceo Albert bourla says 1/4 vaccination would be necessary in order to keep hospitalizations low and illness is mild. In an interview with face the nation bourla explained why it would be ...
Pfizer CEO Albert Bourla said on Monday he had tested positive for Covid-19 and was experiencing very mild symptoms. Subscribe to read this story ad-free Get unlimited access to ad-free articles and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results